Aging and the Microbiome: precondition for gastrointestinal carcinogenesis
Best Practice & Research Clinical Gastroenterology · 2026-08 · 83 · 102122
DOI: 10.1016/j.bpg.2026.102122 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2026-08. Verfasst von Jonas Wizenty und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Be…. Hauptthemen laut MEDLINE: Aging, Gastrointestinal Microbiome, Gastrointestinal Neoplasms, Carcinogenesis. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Einstein Foundation Berlin, Berlin Institute of Health at Charité, Bundesministerium für Forschung Technologie und Raumfahrt Informationstechnikzentrum Bund.
Abstract (Originalsprache)
This review summarizes how aging-related changes in the gut microbiome contribute to gastrointestinal carcinogenesis. We highlight that cancer risk in aging is shaped not only by chronological age but largely by diet, lifestyle, environment, and their impact on microbial ecology. In healthy aging, microbial diversity is preserved with functional redundancy among short-chain fatty acid-producing commensals that support barrier integrity, immune regulation, and metabolic homeostasis. In unhealthy aging, loss of beneficial taxa, expansion of pathobionts, and accumulation of pro-inflammatory and genotoxic metabolites promote chronic inflammation, epithelial dysfunction, and DNA damage, thereby facilitating tumour development. Key microbial drivers include pks + Escherichia coli, enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum, acting through genotoxic, inflammatory, and immune-evasive mechanisms. Although microbiome-targeted interventions such as diet modification, probiotics, faecal microbiota transfer, and phage-based strategies are promising, current evidence remains largely preclinical or observational. Overall, the gut microbiome is a central, modifiable mediator of aging-associated gastrointestinal cancer risk, but longitudinal studies are needed to establish causality and therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmed…
- Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK) and Campus Charité Mitte (CCM), Berlin, Germany; Berlin Institute for Medical Systems Biology (BIMSB), M…
Förderung
- Einstein Foundation Berlin
- Berlin Institute of Health at Charité
- Bundesministerium für Forschung Technologie und Raumfahrt Informationstechnikzentrum Bund
- German Research Foundation
Zitieren
APA
Wizenty, J., & Sigal, M. (2026). Aging and the Microbiome: precondition for gastrointestinal carcinogenesis. Best Practice & Research Clinical Gastroenterology, 83, 102122. https://doi.org/10.1016/j.bpg.2026.102122
Vancouver
Wizenty J, Sigal M. Aging and the Microbiome: precondition for gastrointestinal carcinogenesis. Best Practice & Research Clinical Gastroenterology. 2026;83:102122. doi:10.1016/j.bpg.2026.102122
BibTeX
@article{Wizenty2026,
author = {Wizenty, Jonas and Sigal, Michael},
title = {Aging and the Microbiome: precondition for gastrointestinal carcinogenesis},
journal = {Best Practice & Research Clinical Gastroenterology},
year = {2026},
volume = {83},
pages = {102122},
doi = {10.1016/j.bpg.2026.102122}
}
EUVIMED